<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="120962">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01839071</url>
  </required_header>
  <id_info>
    <org_study_id>10-077</org_study_id>
    <nct_id>NCT01839071</nct_id>
  </id_info>
  <brief_title>Influence of Vasculary Inflammation on Development of Diabetes</brief_title>
  <official_title>Influence of Vasculary Inflammation on Development of Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RWTH Aachen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RWTH Aachen University</source>
  <oversight_info>
    <authority>Germany: Ministry of Work, Health and Social Affairs in North Rhine-Westph</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate if patients with coronary heart disease have
      higher risk to develop diabetes mellitus among the following two years.

      The examination of biomarkers taken from blood and fat issue shall provide which factors
      could be responsible for development of diabetes mellitus.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Fat tissue biopsy</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Patients with Coronary artery disease(CAD) undergo a subcutane fat tissue biopsy to identify inflammation and diabetes biomarker, such as TNF, Adiponectin and Clock-Gene. This is done baseline, after 1 year and after 2 years. Comparison of the current measurements among the measurements of the following 2 years shall give evidence about the reasons and conditions of diabetes development.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood collection</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Blood of patients with Coronary artery disease(CAD)is taken to identify biomarkers of inflammation and diabetes, such as CRP, HbA1c, Adiponectin, Plasma MMp-9, s-ICAM-1, s-VCAM-1, P-selectin and Clock-Gene, CD11b/CD18, CD14, L-selectin, CD-64 and TNF. This is done baseline, after 1 year and after 2 years. Comparison of the current measurements among the measurements of the following 2 years shall give an evidence about the reasons and conditions of diabetes development.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Coronary Artery Disease(CAD)</condition>
  <arm_group>
    <arm_group_label>biopsy of fat tissue</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>biopsy</intervention_name>
    <arm_group_label>biopsy of fat tissue</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients with MI

          -  signed informed consent

          -  older than 18 years

          -  ability to give informed consent

        Exclusion Criteria:

          -  absence of legal competence
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christian Heinrich, MD</last_name>
    <phone>+49 241 8035137</phone>
    <email>cheinrich@ukaachen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ulrike Kirchfeld</last_name>
    <phone>+49 241 8036382</phone>
    <email>ukirchfeld@ukaachen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Aachen</name>
      <address>
        <city>Aachen</city>
        <state>North Rhine Westfalia</state>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Heinrich, MD</last_name>
      <phone>+49 241 8035137</phone>
      <email>cheinrich@ukaachne.de</email>
    </contact>
    <contact_backup>
      <last_name>Ulrike Kirchfeld</last_name>
      <phone>+49 241 8036382</phone>
      <email>ukirchfeld@ukaachen.de</email>
    </contact_backup>
    <investigator>
      <last_name>Christian Heinrich, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 24, 2013</lastchanged_date>
  <firstreceived_date>March 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
